Marc-Olivier Montjovent
Overview
Explore the profile of Marc-Olivier Montjovent including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Montjovent M, Zou L, Faust H, Abdolzade-Bavil A, Liu P, Struwe P
Bioanalysis
. 2017 Sep;
9(18):1385-1393.
PMID: 28956633
Aim: Recombinant glycoprotein produced in nonhuman mammalian cell lines can be modified with the immunogenic nonhuman sialic N-glycolylneuraminic acid (Neu5Gc). We describe here a validated method for detection of antidrug...
2.
Montjovent M, Siegrist M, Klenke F, Wetterwald A, Dolder S, Hofstetter W
Bone
. 2012 Dec;
53(1):79-86.
PMID: 23207801
Delayed fracture healing and non-unions represent rare but severe complications in orthopedic surgery. Further knowledge on the mechanisms of the bone repair process and of the development of a pseudoarthrosis...
3.
Montjovent M, Bocelli-Tyndall C, Scaletta C, Scherberich A, Mark S, Martin I, et al.
Tissue Eng Part A
. 2009 Feb;
15(7):1523-32.
PMID: 19196143
We describe herein some immunological properties of human fetal bone cells recently tested for bone tissue-engineering applications. Adult mesenchymal stem cells (MSCs) and osteoblasts were included in the study for...
4.
Montjovent M, Mark S, Mathieu L, Scaletta C, Scherberich A, Delabarde C, et al.
Bone
. 2008 Jan;
42(3):554-64.
PMID: 18178142
Fetal bone cells were shown to have an interesting potential for therapeutic use in bone tissue engineering due to their rapid growth rate and their ability to differentiate into mature...
5.
Pioletti D, Montjovent M, Zambelli P, Applegate L
Swiss Med Wkly
. 2007 Sep;
137 Suppl 155:86S-89S.
PMID: 17874509
Different cell sources for bone tissue engineering are reviewed. In particular, adult cell source strategies have been based on the implantation of unfractionated fresh bone marrow; purified, culture expanded mesenchymal...
6.
Montjovent M, Mathieu L, Schmoekel H, Mark S, Bourban P, Zambelli P, et al.
J Biomed Mater Res A
. 2007 Mar;
83(1):41-51.
PMID: 17377968
Bioresorbable scaffolds made of poly(L-lactic acid) (PLA) obtained by supercritical gas foaming were recently described as suitable for tissue engineering, portraying biocompatibility with primary osteoblasts in vitro and interesting mechanical...
7.
Pioletti D, Montjovent M, Zambelli P, Applegate L
Swiss Med Wkly
. 2006 Oct;
136(35-36):557-60.
PMID: 17043947
Different cell sources for bone tissue engineering are reviewed. In particular, adult cell source strategies have been based on the implantation of unfractionated fresh bone marrow; purified, culture expanded mesenchymal...
8.
Montjovent M, Mathieu L, Hinz B, Applegate L, Bourban P, Zambelli P, et al.
Tissue Eng
. 2006 Jan;
11(11-12):1640-9.
PMID: 16411809
The aim of this investigation was to test the biocompatibility of three-dimensional bioresorbable foams made of poly(L-lactic acid) (PLA), alone or filled with hydroxyapatite (HA) or beta-tricalcium phosphate (beta-TCP), with...
9.
Montjovent M, Burri N, Mark S, Federici E, Scaletta C, Zambelli P, et al.
Bone
. 2004 Dec;
35(6):1323-33.
PMID: 15589213
We envision the use of human fetal bone cells for engineered regeneration of adult skeletal tissue. A description of their cellular function is then necessary. To our knowledge, there is...